LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 513 | 6485 | 10362 | 0.6257 | 0.7947 |
MCF 10A | YM 201636 | 1.11 | uM | LJP5 | 72 | hr | 513 | 6499 | 10362 | 0.6271 | 0.7952 |
MCF 10A | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 513 | 6501 | 10473 | 0.6206 | 0.7920 |
MCF 10A | Alpelisib | 1.11 | uM | LJP5 | 72 | hr | 513 | 6513 | 10362 | 0.6288 | 0.7952 |
BT-20 | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1657 | 6589 | 5588 | 1.1796 | 1.1970 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 6595 | 10362 | 0.6365 | 0.8012 |
MCF 10A | Radicicol | 0.04 | uM | LJP5 | 72 | hr | 513 | 6621 | 10362 | 0.6390 | 0.8035 |
MCF 10A | Ruxolitinib | 10 | uM | LJP5 | 72 | hr | 513 | 6672 | 10362 | 0.6443 | 0.8063 |
MCF 10A | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 513 | 6771 | 10473 | 0.6464 | 0.8082 |
MCF 10A | BMS345541 | 10 | uM | LJP6 | 72 | hr | 513 | 6788 | 10473 | 0.6483 | 0.8058 |
MCF 10A | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 513 | 6866 | 10473 | 0.6556 | 0.8138 |
BT-20 | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 1657 | 6867 | 5588 | 1.2290 | 1.2497 |
MCF 10A | SNS-032 | 0.04 | uM | LJP6 | 72 | hr | 513 | 6891 | 10473 | 0.6577 | 0.8158 |
MCF 10A | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 513 | 6915 | 10362 | 0.6671 | 0.8212 |
MCF 10A | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 513 | 6950 | 10473 | 0.6637 | 0.8200 |
MCF 10A | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 513 | 6953 | 10473 | 0.6641 | 0.8199 |
MCF 10A | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 6977 | 10362 | 0.6731 | 0.8253 |
MCF 10A | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 513 | 6980 | 10473 | 0.6666 | 0.8219 |
MCF 10A | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 513 | 7006 | 10473 | 0.6688 | 0.8230 |
MCF 10A | WH-4-025 | 0.12 | uM | LJP5 | 72 | hr | 513 | 7014 | 10362 | 0.6771 | 0.8275 |
MCF 10A | Y39983 | 1.11 | uM | LJP6 | 72 | hr | 513 | 7021 | 10473 | 0.6704 | 0.8243 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 7067 | 10473 | 0.6749 | 0.8271 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 7087 | 10362 | 0.6844 | 0.8318 |
MCF 10A | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 513 | 7123 | 10473 | 0.6802 | 0.8304 |
MCF 10A | PLX-4720 | 10 | uM | LJP5 | 72 | hr | 513 | 7135 | 10362 | 0.6888 | 0.8350 |